MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

A

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Search

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

29.18 2.67

Overview

Share price change

24h

Current

Min

27.84

Max

29.27

Key metrics
By Trading Economics
Income	-28M 22M
Sales	4.3M 244M
P/E Sector Avg	10.225 66.418
Profit margin	9.224
Employees	293
EBITDA	-22M 52M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+44.89% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	55M 1.6B
Previous open	26.51
Previous close	29.18

News Sentiment

By Acuity

43%

57%

153 / 349 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 kwi 2026, 20:44 UTC

Earnings

Costco Reports 11% Growth in March Sales

8 kwi 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 kwi 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 kwi 2026, 23:36 UTC

Market Talk

Major News Events

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 kwi 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 kwi 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 kwi 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 kwi 2026, 21:52 UTC

Major News Events

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 kwi 2026, 21:24 UTC

Earnings

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 kwi 2026, 21:01 UTC

Major News Events

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle Responds to TRC Cap Mini-Tender Offer

8 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 kwi 2026, 19:44 UTC

Earnings

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 kwi 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8 kwi 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8 kwi 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 kwi 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 kwi 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 kwi 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 kwi 2026, 18:14 UTC

Major News Events

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 kwi 2026, 18:05 UTC

Major News Events

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

44.89% upside

12 Months Forecast

Average 41.25 USD 44.89%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

3

Hold

1

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

153 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Other stocks from the sector

MDT

Medtronic PLC

87.92

A

Agilent Technologies Inc

115.46

VEEV

Veeva Systems Inc

157.06

HQY

HealthEquity Inc

83.88

TLRY

Tilray Brands Inc

6.71

Live chat